We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
DD's MemCor MBR System Chosen for Major Plant Upgrade in Australia
Read MoreHide Full Article
Key Takeaways
DuPont's MemCor MBR system was selected for a major wastewater treatment upgrade in Canberra.
The system will provide about 97 million liters per day of treatment capacity and will be made in Australia.
DuPont says rising population and infrastructure investment are driving demand for scalable water solutions.
DuPont de Nemours, Inc. (DD - Free Report) recently announced that its MemCor membrane bioreactor (“MBR”) system has been selected for the expansion of the treatment facility at the Lower Molonglo Water Quality Control Center (“LMWQCC”) in Canberra, Australia. The project will help the facility address rising wastewater treatment demand driven by population growth.
The LMWQCC, owned and operated by Icon Water, is the largest inland wastewater treatment facility in Australia and has been operational since the late 1970s. As part of its major upgrade in collaboration with Seymour Whyte and VINCI Construction Grands Projects, the facility will add a new secondary treatment process based on advanced membrane technology.
DuPont’s MemCor MBR system will provide a treatment capacity of approximately 97 million liters per day, enabling the facility to support Canberra’s requirements. The system will also be manufactured in Australia, highlighting DuPont’s ability to combine global technology with local expertise.
The selection strengthens DuPont’s position in the market, where demand for efficient and scalable solutions is increasing alongside population growth and infrastructure investment. MemCor MBR systems, along with MemPulse modules, have been deployed across hundreds of municipal and industrial installations worldwide, building a high reputation based on high reliability.
DuPont’s Water Solutions portfolio includes membranes, resins and complete treatment systems serving municipalities, desalination plants and industrial users across 112 countries. The project further demonstrates the company’s role in addressing growing global water-treatment needs.
DD’s shares have lost 33.4% over the past year against the industry’s 7.4% rise.
Image Source: Zacks Investment Research
DD’s Zacks Rank & Key Picks
DD currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Neo Performance Materials Inc. (NOPMF - Free Report) , Carpenter Technology Corporation (CRS - Free Report) and Avient Corporation (AVNT - Free Report) .
The Zacks Consensus Estimate for NOPMF’s 2026 earnings is pinned at $1.48 per share, indicating a 202.04% year-over-year increase. NOPMF’s shares have gained 113.7% over the past year.
The Zacks Consensus Estimate for CRS’ fiscal 2027 earnings is pegged at $12.92 per share, indicating a rise of 20.07% year over year. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 8.39%.
The Zacks Consensus Estimate for AVNT’s current-year earnings is pinned at $3.17 per share, indicating a 12.41% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 3.4%. AVNT’s shares have gained 29.5% over the past year.
Image: Bigstock
DD's MemCor MBR System Chosen for Major Plant Upgrade in Australia
Key Takeaways
DuPont de Nemours, Inc. (DD - Free Report) recently announced that its MemCor membrane bioreactor (“MBR”) system has been selected for the expansion of the treatment facility at the Lower Molonglo Water Quality Control Center (“LMWQCC”) in Canberra, Australia. The project will help the facility address rising wastewater treatment demand driven by population growth.
The LMWQCC, owned and operated by Icon Water, is the largest inland wastewater treatment facility in Australia and has been operational since the late 1970s. As part of its major upgrade in collaboration with Seymour Whyte and VINCI Construction Grands Projects, the facility will add a new secondary treatment process based on advanced membrane technology.
DuPont’s MemCor MBR system will provide a treatment capacity of approximately 97 million liters per day, enabling the facility to support Canberra’s requirements. The system will also be manufactured in Australia, highlighting DuPont’s ability to combine global technology with local expertise.
The selection strengthens DuPont’s position in the market, where demand for efficient and scalable solutions is increasing alongside population growth and infrastructure investment. MemCor MBR systems, along with MemPulse modules, have been deployed across hundreds of municipal and industrial installations worldwide, building a high reputation based on high reliability.
DuPont’s Water Solutions portfolio includes membranes, resins and complete treatment systems serving municipalities, desalination plants and industrial users across 112 countries. The project further demonstrates the company’s role in addressing growing global water-treatment needs.
DD’s shares have lost 33.4% over the past year against the industry’s 7.4% rise.
Image Source: Zacks Investment Research
DD’s Zacks Rank & Key Picks
DD currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Neo Performance Materials Inc. (NOPMF - Free Report) , Carpenter Technology Corporation (CRS - Free Report) and Avient Corporation (AVNT - Free Report) .
While NOPMF currently sports a Zacks Rank #1 (Strong Buy), CRS and AVNT carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for NOPMF’s 2026 earnings is pinned at $1.48 per share, indicating a 202.04% year-over-year increase. NOPMF’s shares have gained 113.7% over the past year.
The Zacks Consensus Estimate for CRS’ fiscal 2027 earnings is pegged at $12.92 per share, indicating a rise of 20.07% year over year. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 8.39%.
The Zacks Consensus Estimate for AVNT’s current-year earnings is pinned at $3.17 per share, indicating a 12.41% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 3.4%. AVNT’s shares have gained 29.5% over the past year.